Patents by Inventor Joel Raingeaud

Joel Raingeaud has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Isolated peptides and fragments thereof from fibrinogen for use as drugs, particularly in skin inflammatory diseases
    Patent number: 10323078
    Abstract: A present invention relates to isolated peptides obtained from human fibrinogen for their use as drug, particularly for the prevention and/or the treatment of inflammatory skin diseases, more particularly acne. The present invention also relates to fragments of these polypeptides, nucleic acid molecules encoding them, expression vectors, host cells, a pharmaceutical composition and a combination product containing them, and their use for treating and/or preventing inflammatory skin diseases, particularly acne.
    Type: Grant
    Filed: March 21, 2016
    Date of Patent: June 18, 2019
    Assignees: Universite Paris Descartes, Assistance Publique—Hopitaux De Paris, Universite Paris—Sud, Universite Pierre et Marie Curie (Paris 6), Institut National De La Sante et De La Recherche Medicale (INSERM), Centre National De La Recherche Scientifique (CNRS), Institut Gustave-Roussy
    Inventors: Nicolas Dupin, Philippe Grange, Vincent Calvez, Joël Raingeaud
  • ISOLATED PEPTIDES AND FRAGMENTS THEREOF FROM FIBRINOGEN FOR USE AS DRUGS, PARTICUARLY IN SKIN INFLAMMATORY DISEASES
    Publication number: 20180105574
    Abstract: A present invention relates to isolated peptides obtained from human fibrinogen for their use as drug, particularly for the prevention and/or the treatment of inflammatory skin diseases, more particularly acne. The present invention also relates to fragments of these polypeptides, nucleic acid molecules encoding them, expression vectors, host cells, a pharmaceutical composition and a combination product containing them, and their use for treating and/or preventing inflammatory skin diseases, particularly acne.
    Type: Application
    Filed: March 21, 2016
    Publication date: April 19, 2018
    Applicants: Universite Paris Descartes, Assistance Publique - Hopitaux de Paris, Universite Paris - SUD, Universite Pierre et Marie Curie (Paris 6), Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Institut Gustave-Roussy
    Inventors: Nicolas Dupin, Philippe Grange, Vincent Calvez, Joël Raingeaud
  • Optical Disc Apparatus
    Publication number: 20090053231
    Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
    Type: Application
    Filed: June 18, 2008
    Publication date: February 26, 2009
    Inventors: Roger J. Davis, Joel Raingeaud, Benoit Derijard
  • Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
    Publication number: 20050272077
    Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
    Type: Application
    Filed: April 21, 2005
    Publication date: December 8, 2005
    Inventors: Roger Davis, Joel Raingeaud, Benoit Derijard
  • Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
    Patent number: 6541605
    Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
    Type: Grant
    Filed: April 7, 1998
    Date of Patent: April 1, 2003
    Assignee: University of Massachusetts
    Inventors: Roger J. Davis, Joel Raingeaud, Benoit Derijard
  • Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
    Publication number: 20020102691
    Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
    Type: Application
    Filed: January 16, 2001
    Publication date: August 1, 2002
    Applicant: University of Massachusetts, a Massachusetts corporation
    Inventors: Roger J. Davis, Joel Raingeaud, Benoit Derijard
  • Cytokine-stress- and oncoprotein-activated human protein kinase kinases
    Patent number: 6174676
    Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human-MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
    Type: Grant
    Filed: September 8, 1998
    Date of Patent: January 16, 2001
    Assignee: University of Massachusetts
    Inventors: Roger J. Davis, Joel Raingeaud, Benoit Derijard
  • Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
    Patent number: 5804427
    Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: September 8, 1998
    Assignee: University of Massachusetts
    Inventors: Roger Davis, Joel Raingeaud, Benoit Derijard
  • Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases
    Patent number: 5736381
    Abstract: Disclosed are human mitogen-activated (MAP) kinase kinase isoforms (MKKs). MKKs mediate unique signal transduction pathways that activate human MAP kinases p38 and JNK, which result in activation of other factors, including activating transcription factor-2 (ATF2) and c-Jun. The pathways are activated by a number of factors, including cytokines and environmental stress. Methods are provided for identifying reagents that modulate MKK function or activity and for the use of such reagents in the treatment of MKK-mediated disorders.
    Type: Grant
    Filed: September 19, 1995
    Date of Patent: April 7, 1998
    Inventors: Roger J. Davis, Shashi Gupta, Joel Raingeaud, Benoit Derijard